NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -231.86% | -159.57% | 164.80% | -64.46% | 40.48% |
| Total Depreciation and Amortization | -0.15% | -2.53% | -0.26% | -0.98% | -0.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.20% | 3.50% | -33.60% | 46.08% | -18.34% |
| Change in Net Operating Assets | -84.73% | 222.35% | -242.66% | 578.67% | -139.05% |
| Cash from Operations | -67.95% | 2,598.99% | -106.16% | 224.02% | -54.35% |
| Capital Expenditure | 77.56% | -200.85% | -391.67% | 88.76% | -29.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 45.01% | -200.85% | -391.67% | 88.05% | -22.01% |
| Total Debt Issued | -- | -- | -100.00% | 26,100.00% | -200.00% |
| Total Debt Repaid | 1.57% | -30.30% | 93.05% | -1,675.00% | 25.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 85.71% | -432.00% | 12.28% | -137.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,104.00% | -81.34% | 332.26% | 29.17% | 0.00% |
| Cash from Financing | 29.76% | -130.05% | -337.59% | 139.68% | 13.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.19% | 235.54% | -140.22% | 773.99% | -182.64% |